Institute of Global Innovation Research
|Date||2019.7.25 (16 : 00 - 17：30)|
|Venue||Room 32, New Building 4, Fuchu Campus TUAT|
|Speaker / Topic||Dr. Hirohito Yamaguchi
(Senior Scientist, Cancer Research Center, Qatar Biomedical Research Institute)
"Molecular classification of breast cancer for personalized cancer therapy"
Breast cancer is a major health burden worldwide affecting 1 out of 4 women. It has been recognized that breast cancer is a heterogeneous disease with multiple biological subtypes. Understanding of these biological subtypes of breast cancer is essential not only for breast cancer diagnosis and prognosis, but also for selecting efficient treatment strategies and predicting treatment responses. In this seminar, I will explain the molecular subtypes of breast cancer that are associated with disease prognosis and therapeutic strategies. Moreover, I will introduce the various targeted drugs specific for some subtypes of breast cancer, many of which have recently approved by US Federal drug administration (FDA), and discuss the challenges of personalized therapy for breast cancer.
|Intended for||Everyone is welcome to attend.|
|Co-Organized by||Institute of Global Innovation Research “Life Science” Nagaoka Team
Excellent Leader Development for Super Smart Society by New Industry Creation and Diversity
|Contact||Institute of Global Innovation Research
Prof. Kentaro Nagaoka
COPYRIGHT 2019 ©TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY., ALL RIGHTS RESERVED.
Close the menu